|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1997-3-31
|
|
pubmed:abstractText |
128 untreated cases of Kala-azar were divided in 4 equal groups of 32, Group A was treated with Sodium Stibogluconate (SSG) in the dose of 20 mg/kg/body wt. for 30 days. Group B was treated SSG plus allopurinol in the dose of 20 mg/kg/body wt. orally in divided dosage for 30 days. Group C received SSG plus Ketoconazole 600 mg orally in divided dosage for 30 days. Group D in addition to SSG also received levamisole in single oral daily dose of 13 mg/kg/body wt. for 30 days. Response of Group B, C and D was compared to Group A. Results from this study revealed combination of allopurinol with SSG to be statistically not superior to SSG alone.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0004-5772
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
319-20
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9081958-Adult,
pubmed-meshheading:9081958-Allopurinol,
pubmed-meshheading:9081958-Antimony Sodium Gluconate,
pubmed-meshheading:9081958-Antiprotozoal Agents,
pubmed-meshheading:9081958-Dose-Response Relationship, Drug,
pubmed-meshheading:9081958-Drug Administration Schedule,
pubmed-meshheading:9081958-Drug Therapy, Combination,
pubmed-meshheading:9081958-Female,
pubmed-meshheading:9081958-Humans,
pubmed-meshheading:9081958-Ketoconazole,
pubmed-meshheading:9081958-Leishmaniasis, Visceral,
pubmed-meshheading:9081958-Levamisole,
pubmed-meshheading:9081958-Male
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Combination therapy in Kala-azar.
|
|
pubmed:affiliation |
Kala-azar Research Centre, Barhmpura, Muzaffarpur.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
